Key result
Specific RNA sequences activate stress kinase PKR to regulate mRNA, creating novel targets for hereditary diseases.
Why the study?
Analyzing mutations within human genes that encode PKR-activating RNA structures can delineate their folding and reveal novel potential RNA targets for human disease.
Intragenic RNA activators of PKR play a critical role in gene regulation, and mutations in these structures present novel therapeutic targets for hereditary diseases.
Hypothesis-generating for PKR-targeted therapies in hereditary diseases; animal data leaves open human translation.
Specific sequences within RNA encoded by human genes essential for survival possess the ability to activate the RNA-dependent stress kinase PKR, resulting in phosphorylation of its substrate, eukaryotic translation initiation factor-2α (eIF2α), either to curb their mRNA translation or to enhance mRNA splicing. Thus, interferon-γ (IFNG) mRNA activates PKR through a 5′-terminal 203-nucleotide pseudoknot structure, thereby strongly downregulating its own translation and preventing a harmful hyper-inflammatory response. Tumor necrosis factor-α (TNF) pre-mRNA encodes within the 3′-untranslated region (3′-UTR) a 104-nucleotide RNA pseudoknot that activates PKR to enhance its splicing by an order of magnitude while leaving mRNA translation intact, thereby promoting effective TNF protein expression. Adult and fetal globin genes encode pre-mRNA structures that strongly activate PKR, leading to eIF2α phosphorylation that greatly enhances spliceosome assembly and splicing, yet also structures that silence PKR activation upon splicing to allow for unabated globin mRNA translation essential for life. Regulatory circuits resulting in each case from PKR activation were reviewed previously. Here, we analyze mutations within these genes created to delineate the RNA structures that activate PKR and to deconvolute their folding. Given the critical role of intragenic RNA activators of PKR in gene regulation, such mutations reveal novel potential RNA targets for human disease.
No takes yet. Share an insight, caveat, or question.
Raymond Kaempfer (2024) conducted a review in Hereditary Diseases. Mutations in intragenic RNA activators of PKR was evaluated. Specific RNA sequences within human genes such as IFNG, TNF, and globin activate the stress kinase PKR to regulate mRNA splicing or translation, creating novel potential targets for hereditary diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: